Intellectual Property & Health | News To Know - France & Europe - September 2021

Patent and trademark issues effecting pharmaceutical laboratories, biotechs, food supplements and dietary products professionals, cosmetics companies and medical devices manufacturers is continually evolving across France and the EU. We are regularly monitoring key cases and news, to provide insights as to how this impacts business within your sector.

DRAFT LAW – FIGHT AGAINST COUNTERFEITING – INTERNET – CUSTOMS POWERS -

On June 15, 2021, a bill to modernize the fight against counterfeiting (No. 4246) was tabled in the French National Assembly. Some of the provisions, in particular its Articles 11 and 15, aim to more effectively combat counterfeit medicines...

APPLICATION FOR INTERIM MEASURES – COUNTERCLAIM FOR PATENT INVALIDITY – INVENTIVE STEP – PLAUSIBILITY OF THE INVENTION -

TJ Paris [Judicial Court of Paris], May 12, 2021, Sanofi v. Teva (No. RG 21/53136) The Court found the defendant’s arguments to be sufficiently serious to call into question the apparent validity of the asserted patent and to reject plaintiff’s request for interim measures...

Please see full publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McDermott Will & Emery | Attorney Advertising

Written by:

McDermott Will & Emery
Contact
more
less

McDermott Will & Emery on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide